Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
RSV (respiratory syncytial virus) poses the greatest danger to infants and older adults. In babies, the immune system is still developing, and their small airways can quickly become inflamed or blocked. In seniors, age-related immune decline and underlying conditions like heart or lung disease make it harder to fight the infection, often leading to pneumonia or hospitalization.
Because early RSV symptoms can look like a common cold, it's easy to underestimate. If you or a loved one is experiencing respiratory symptoms, take a free, instant, online symptom check to better understand what may be going on and confidently plan your next steps.
Reviewed for medical accuracy: 07/20/2026
Not seeing your question? No worries.
Submit your own QuestionRespiratory Syncytial Virus (RSV) can be particularly dangerous for infants and older adults due to differences in their immune systems.
Infants: Babies, especially those under six months old, have immature immune systems that are not fully equipped to combat infections like RSV. Their small airways can also become easily blocked by the inflammation caused by the virus, leading to breathing difficulties.
Older Adults: As people age, their immune systems naturally weaken, which means they are less able to fight off infections. Seniors with other health conditions, like heart or lung diseases, are at even greater risk of severe illness from RSV.
In both groups, RSV can lead to serious respiratory problems, such as pneumonia or bronchiolitis. If you or a loved one is experiencing respiratory symptoms, you can use a free symptom checker to help assess your condition and determine whether medical attention may be needed. This makes it important to take preventive measures, such as good hygiene practices and, when available, vaccination, to protect these vulnerable populations.
(References)
Kelleher K, Subramaniam N, & Drysdale SB. (2025). The recent landscape of RSV vaccine research. Therapeutic advances in vaccines and immunotherapy, 39802673.
Openshaw PJM, Chiu C, Culley FJ, & Johansson C. (2017). Protective and Harmful Immunity to RSV Infection. Annual review of immunology, 28226227.
Hall CB, Simőes EA, & Anderson LJ. (2013). Clinical and epidemiologic features of respiratory syncytial .... Current topics in microbiology and immunology, 24362683.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.